Teva Pharmaceutical Industries (TEVA) is back in focus after investors reacted to progress on its shift from a traditional generics business toward higher margin branded medicines, anchored by Austedo...
Source LinkTeva Pharmaceutical Industries (TEVA) is back in focus after investors reacted to progress on its shift from a traditional generics business toward higher margin branded medicines, anchored by Austedo...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.